Table 3.
Acylcarnitine profile of the patient before and after riboflavin treatment
| Analytes | Results | Reference range | Units | |
|---|---|---|---|---|
| Before | After | |||
| C0- Free carnitine | 36 | 42 | 17–64 | umol/L |
| C2- Acetylcarnitine | 10 | 3 | 2-17 | umol/L |
| C3-Propionylcarnitine | 0.42 | 0.31 | 0.14–0.95 | umol/L |
| C3DC-Malonylcarnitine | 0.03 | 0.03 | 0.01–0.08 | umol/L |
| C4-n-butyryl−/isobutyrylcarnitine | 0.33 | 0.16 | 0.08–0.46 | umol/L |
| C4OH-3-Hydroxy-Butyrylcarnitine | 0.12 | 0.06 | 0.01–0.24 | umol/L |
| C5-Isovaleryl−/2-Methylbutyrylcarnitine | 0.39 | 0.10 | 0.03–0.32 | umol/L |
| C5:1-Tiglylcarnitine | 0.02 | 0.01 | 0.01–0.04 | umol/L |
| C5OH-3-Hydroxy-Isovaerylcarnitine | 0.03 | 0.03 | 0.01–0.09 | umol/L |
| C5DC-Glutaryl/3-Hydroxydecanoylcarnitine | 0.28 | 0.06 | 0.010.08 | umol/L |
| C6-Hexanoylcarnitine | 0.43 | 0.25 | 0.02–0.12 | umol/L |
| C8-Octanoylcarnitine | 1.50 | 1.69 | 0.03–0.22 | umol/L |
| C10-Decanoylcarnitine | 3.07 | 1.82 | 0.05–0.42 | umol/L |
| C10:1-Decenoylcarnitine | 0.40 | 0.61 | 0.03–0.26 | umol/L |
| C10:2-Decadienoylcarnitine | 0.05 | 0.05 | 0.01–0.05 | umol/L |
| C12-Dodecanoylcarnitine | 0.87 | 0.15 | 0.02–0.13 | umol/L |
| C12:1-Dodecenoylcarnitine | 0.13 | 0.09 | 0.01–0.10 | umol/L |
| C14-Tetradecanoylcarnitine | 0.51 | 0.05 | 0.01–0.07 | umol/L |
| C14:1-Tetradecenoylcarnitine | 0.72 | 0.15 | 0.01–0.17 | umol/L |
| C14:2-Tetradecadienoylcarnitine | 0.20 | 0.07 | 0.01–0.05 | umol/L |
| C16-Hexadecanoylcarnitine | 0.81 | 0.13 | 0.06–0.24 | umol/L |
| C16:1-Hexadecenoylcarnitine | 0.53 | 0.05 | 0.01–0.07 | umol/L |
| C18-Octadecanoylcarnitine | 0.34 | 0.04 | 0.02–0.10 | umol/L |
| C18:1-Octadecenoylcarnitine | 0.95 | 0.12 | 0.05–0.28 | umol/L |
| C18:2-Linoleylcarnitine | 0.33 | 0.05 | 0.02–0.10 | umol/L |
| C16OH-3-Hydroxy-Hexadecanoylcarnitine | 0.02 | 0.01 | 0.00–0.02 | umol/L |
Numbers out of reference range are in bold